Cancer risks along the disease trajectory in antineutrophil cytoplasmic antibody associated vasculitis Zaw ThetAlfred K. LamTien K. Khoo Review Article 26 March 2020 Pages: 2501 - 2513
Human immunodeficiency virus infection (HIV)–associated rheumatic manifestations in thepre- and post-HAART eras Luis E. VegaLuis R. Espinoza Review Article 15 April 2020 Pages: 2515 - 2522
Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases Yanfeng BaoChen DongZhifeng Gu Review Article 09 June 2020 Pages: 2523 - 2528
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad Sakir AhmedOlena ZimbaArmen Yuri Gasparyan Review Article 11 July 2020 Pages: 2529 - 2543
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia Paul BirdGeoffrey LittlejohnHedley Griffiths Original Article 10 March 2020 Pages: 2545 - 2551
Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα Minh Vu Chuong NguyenAnaïs CourtierPhilippe Gaudin Original Article 24 March 2020 Pages: 2553 - 2562
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study- Kosuke EbinaToru HiranoMakoto Hirao Original Article 11 March 2020 Pages: 2563 - 2572
The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs Juan ZhaoXia YeZhuoli Zhang Original Article 23 March 2020 Pages: 2573 - 2581
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study Frank BehrensHans-Peter TonyMarc Schmalzing Original Article Open access 23 March 2020 Pages: 2583 - 2592
Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT Veerle StoutenStijn MichielsPatrick Verschueren Original Article 12 March 2020 Pages: 2593 - 2601
Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren’s syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis Nevin HammamNada M. GamalTamer A. Gheita Original Article 23 March 2020 Pages: 2603 - 2610
The decreased expression of IKBKE in systemic lupus erythematosus Tingting ZhuJiaqi HongLu Liu Original Article Open access 07 March 2020 Pages: 2611 - 2617
Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus Yanli ZengYiqiang LinYun Xiao Original Article 18 March 2020 Pages: 2619 - 2629
Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring Mustafa CandemirBurcu CandemirAdem Ertürk Original Article 25 March 2020 Pages: 2631 - 2639
The changing profile of ankylosing spondylitis in the biologic era John D. ReveilleMinJae LeeMichael H. Weisman Original Article 09 July 2020 Pages: 2641 - 2651
Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis Fangze ZhangCuili MaLiqi Bi Original Article 26 March 2020 Pages: 2653 - 2661
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting Luca NavariniLuisa CostaFrancesco Caso Original Article 18 March 2020 Pages: 2663 - 2670
Microangiopathy and forearm arterial blood flow in systemic sclerosis: a controlled study Amir BieberKatya DolnikovReuven Mader Original Article 10 March 2020 Pages: 2671 - 2676
Association between comorbidities and extraglandular manifestations in primary Sjögren’s syndrome: a multicenter cross-sectional study Yuying ZhangMengtao LiXiaofeng Zeng Original Article 07 March 2020 Pages: 2677 - 2688
Early onset primary Sjögren syndrome, clinical and laboratory characteristics Müçteba Enes YaylaZehra KaramanAşkın Ateş Original Article 27 March 2020 Pages: 2689 - 2696
Clinical features of Behcet’s disease in Mongolia: a multicenter study Javzandulam BaltBaasankhuu JamyanjavNobuyoshi Kitaichi Original Article 10 March 2020 Pages: 2697 - 2706
Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review Noémie AbisrorArsene MekinianNathalie Costedoat-Chalumeau Original Article 23 March 2020 Pages: 2707 - 2713
Syndemic and syndemogenesis of low back pain in Latin-American population: a network and cluster analysis Alfonso Gastelum StrozziIngris Peláez-BallestasOn behalf of GLADERPO (Grupo Latino Americano De Estudio de Pueblos Originarios) Original Article 30 March 2020 Pages: 2715 - 2726
18F-FDG PET/CT in bone sarcoidosis: an observational study Lucie DemariaRaphael BorieSébastien Ottaviani Original Article 20 March 2020 Pages: 2727 - 2734
FDG PET/CT used in identifying adult-onset Still’s disease in connective tissue diseases Xin ZhouYuan LiQian Wang Original Article 16 March 2020 Pages: 2735 - 2742
Founder effects of the homogentisate 1,2-dioxygenase (HGD) gene in a gypsy population and mutation spectrum in the gene among alkaptonuria patients from India Sumita DandaSony MohanIsaac Jebaraj Brief Report 24 March 2020 Pages: 2743 - 2749
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study Patricia RichiOriol AlonsoSantiago Muñoz-Fernández Brief Report 04 April 2020 Pages: 2751 - 2756
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India Padmanabha ShenoySakir AhmedBazil Alias Brief Report 30 May 2020 Pages: 2757 - 2762
A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome Gustavo Luiz Behrens PintoRenata Casseb de Souza CarboniSamuel Katsuyuki Shinjo Original Article 09 March 2020 Pages: 2763 - 2771
Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan Hung-Yi ChenJiun-Jie LinMei-Chen Lin Original Article 09 March 2020 Pages: 2773 - 2780
Persistent chikungunya arthritis in Roraima, Brazil Ramão Luciano Nogueira HaydMaony Rodrigues MorenoAileen Y. Chang Original Article 13 March 2020 Pages: 2781 - 2787
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease C. Sieiro SantosC. Moriano MoralesT. Perez Sandoval Original Article 27 July 2020 Pages: 2789 - 2796
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab Shaozhe CaiWei SunLingli Dong Case Based Review Open access 19 June 2020 Pages: 2797 - 2802
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review Feng HeQingqing LuoLiuping Yang Case Based Review 28 July 2020 Pages: 2803 - 2810
Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology Eduardo Mantovani CardosoJasmin HundalJohn Magaldi Case Based Review 28 July 2020 Pages: 2811 - 2815
Challenges in delivering rheumatology care during COVID-19 pandemic A. NuneK. IyengarH. Sapkota Perspectives in Rheumatology 25 July 2020 Pages: 2817 - 2821
Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis Ashraful HaqueTrevor ClevelandRachael Kilding Clinical Image 08 May 2020 Pages: 2823 - 2824
Sclerochoroidal calcifications associated with early-onset calcium pyrophosphate deposition disease Jacopo CiaffiElena BorlandelliFrancesco Ursini Clinical Image 16 May 2020 Pages: 2825 - 2826
Full histological and clinical regression of morphea with tofacitinib Morton ScheinbergCid SabbaghNilceo Michalany Clinical Image 18 May 2020 Pages: 2827 - 2828
Rheumatoid arthritis and myelodysplastic syndrome: a fortuitous association? Zakaria El OualiKawtar NassarSaadia Janani Letters of Biomedical and Clinical Research 02 May 2020 Pages: 2829 - 2831
Coexistence of antiphospholipid syndrome and cryoglobulinemia in a patient with rheumatoid arthritis Katherine CajiaoJosé A. Gómez-Puerta Letter to the Editor 09 May 2020 Pages: 2833 - 2835
Good response to mycophenolate mofetil on treatment of interstitial lung disease in polymyositis associated with antisynthetase syndrome positive for anti-EJ and anti-Ro52 antibodies Erika A. Martínez-GarcíaAndrea V. Lujano-BenítezMónica Vázquez-Del Mercado Letter to the Editor 26 May 2020 Pages: 2837 - 2839
Comment on “Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases” Shu-Shan ZhaoWei-Min Li Letter to the Editor 16 July 2020 Pages: 2841 - 2842
Correction to: Mortality burden associated with all-cause pneumonia among adults with autoimmune inflammatory rheumatic diseases, human immunodeficiency virus infection, and malignancies: a population-based comparative study for informed decision-making in public health policies Rodrigo Poubel Vieira de RezendeEvandro Mendes KlumbGecilmara Salviato Pileggi Correction 21 July 2020 Pages: 2843 - 2844